Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib therapy helped many patients with severe alopecia regrow hair after 52 weeks.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

Ocoxin improves quality of life for advanced ovarian cancer patients on chemotherapy.

Significant progress and collaborations in stem cell research and regenerative medicine were made, including advancements in hair growth, cancer therapies, and treatments for neurological disorders.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

Combining PRP with Tressfix Serum is more effective for hair regrowth in telogen effluvium than using either alone.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.

Women also use 5α-reductase inhibitors, and their effects differ from men.

Current treatments for alopecia show no significant long-term benefits.

Testosterone with or without finasteride doesn't improve thinking skills in older men with low testosterone.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

Patients felt happier with their looks and younger after hair transplant surgery, but their well-being and social life didn't change much.

Hidradenitis Suppurativa is likely an autoinflammatory disease, and better understanding its causes could improve treatments.

Women with PCOS often have metabolic issues like insulin resistance and a higher risk of diabetes and abnormal lipid levels.

Women with PCOS often have insulin resistance, abnormal lipid levels, and a higher risk of diabetes and heart disease; lifestyle changes and medication like metformin can help manage these risks.

Childhood obesity is rising globally due to various factors, and early prevention and healthy lifestyle changes are crucial.

Testosterone supplements can increase muscle mass and strength in older men with low levels, but long-term effects and risks need more research.

Levetiracetam is widely used and generally well-tolerated for treating idiopathic generalized epilepsies, with tiredness as the main side effect.

5α-reductase inhibitors like finasteride may not be effective or safe for transgender individuals, and more research is needed.

Effective symptom management in IBD improves quality of life and prevents complications.

Hyaluronic acid fillers and combination treatments significantly improve facial defects from autoimmune diseases and are well-tolerated.

Treating hidradenitis suppurativa needs long-term care and teamwork among doctors, but there's a lack of strong guidance on how to do it.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

Continuous baricitinib is needed to keep hair regrowth in severe alopecia areata.

Second-generation antipsychotics offer no significant benefit over first-generation ones for schizophrenia.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Minoxidil and finasteride treat hair loss in men, while minoxidil treats hair loss in women.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.